An innovative PET tracer can measure damage from multiple sclerosis in mouse modelsJanuary 12, 2018
The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark of the immune-mediated neurological disorder multiple sclerosis (MS). When segments of this protective membrane are damaged, nerve impulses can be disrupted. Symptoms range from tingling and numbness to weakness, pain and paralysis.
There is currently no reliable way to directly image demyelination. Physicians rely on magnetic resonance imaging (MRI), but despite high resolution images, MRI is not quantitative and cannot distinguish between demyelination and inflammation, which often coexist in people with MS.
In the January 12, 2017 online issue of the journal Scientific Reports, a multi-institutional team based primarily at the University of Chicago Medicine and the National Institutes of Health, describe early tests of a novel minimally-invasive way to assess myelin damage using positron emission tomography (PET).
These PET scans use a radioactive molecule designed to target voltage-gated potassium channels, a protein found on demyelinated axons. The PET images, based on the detection of this molecule, provide quantitative information about underlying biochemical processes.
"In healthy myelinated neurons, potassium channels are usually buried underneath the myelin sheath," explained study author Brian Popko, PhD, the Jack Miller Professor of Neurological Disorders and director of the center for peripheral neuropathy at the University of Chicago. "When there is loss of myelin, these channels become exposed. They migrate throughout the demyelinated segment and their levels increase."
These exposed neurons leak intracellular potassium. This leaves them unable to propagate electrical impulses, which causes some of the neurological symptoms seen in MS. "So we developed a PET tracer that can target potassium channels," Popko said.
The team started with an existing MS drug, 4-aminopyridine (a.k.a. dalfampridine), which can bind to exposed potassium channels. This can partially restore nerve conduction and alleviate neurological symptoms in MS patients. Using mouse models of MS, including some developed in the Popko lab, the researchers showed that the drug accumulated in the demyelinated, or uncovered, areas of the central nervous system.
Then, with help from colleague Pancho Bezanilla, PhD, professor of biochemistry and molecular biology at the University of Chicago, the team examined several fluorine-containing derivatives of 4-aminopyridine for binding to K+ channels. They found that 3-fluoro-4-aminopyridine (3F4AP) has the desired properties, so they labeled the molecule with fluorine-18, which is easily detected by PET.
"We were able to show, in rats, that the tracer accumulated to a higher degree in demyelinated areas than in control areas," Popko said.
"All existing PET tracers used for imaging demyelination bind to myelin and, consequently, demyelinated lesions show as decreases in signal, which can be problematic for imaging small lesions," said Pedro Brugarolas, PhD, first author of the paper and currently a faculty member at Massachusetts General Hospital/Harvard Medical School. "3F4AP is the first tracer whose signal increases with demyelination, potentially solving some of the problems of its predecessors."
Finally, in collaboration with scientists at the NIH, the researchers conducted a study in healthy monkeys. They confirmed that radiolabeled 3F4AP enters the brain of primates and localizes to areas where there is little myelin.
"We think that this PET approach can provide complementary information to MRI which can help us follow MS lesions over time," Popko said. "It has the potential to track responses to remyelinating therapies, an unmet need. This approach should also help determine how much disruption of the myelin sheath contributes to other central nervous system disorders."
That list includes leukodystrophies, traumatic brain injury, spinal cord injury and "even maladies not traditionally associated with demyelination," Popko suggested, "such as brain ischemia, psychiatric disorders, and neurodegenerative diseases, including Alzheimer's."
"A tracer to monitor changes in something as ubiquitous as potassium channels could have applications for other diseases where these channels are involved," Brugarolas added,
More than 2.3 million people worldwide suffer from multiple sclerosis, according to 2013 data from the MS International Federation. None of the 15 current FDA-approved drugs for MS are able to cure the disease; they modify or suppress the immune system, reducing the number and severity of flare-ups and less often, slowing the visible marks of brain damage.
This research was supported by the National Multiple Sclerosis Society, the National Institute for Neurological Disorders and Stroke, the National Institute for Biomedical Imaging and Bioengineering, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Chicago Innovation Exchange (now known as the Polsky Center).
University of Chicago Medical Center
Related Multiple Sclerosis Articles:
Multiple sclerosis (MS) is a chronic debilitating inflammatory disease targeting the brain.
Multiple sclerosis (MS) clinicians face continued challenges in optimizing neurological care, especially for people with advanced MS living in medically underserved communities.
With a recent two-year, $833,000 grant from the US Department of Defense, kinesiology professor Richard van Emmerik and colleagues at the University of Massachusetts Amherst hope to eventually help an estimated 1 million people worldwide living with progressive multiple sclerosis by creating an improved diagnostic test for this form of the disease, which is characterized by a steady decrease in nervous system function.
Inserm Unit U919, directed by Professor Denis Vivien has developed an antibody with potential therapeutic effects against multiple sclerosis.
Scientists of the Technical University of Munich and the Max Planck Institute of Psychiatry have identified four new risk genes that are altered in German patients with multiple sclerosis.
The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, while providing a means of evaluating next-generation therapies for MS, say researchers introducing a study at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.
Researchers have discovered a rare genetic mutation that makes it probable that a person will develop multiple sclerosis (MS).
The Ikerbasque researcher Koen Vandenbroeck, who heads the Neurogenomiks laboratory which reports to the Achucarro centre and the UPV/EHU-University of the Basque Country, together with other national and international groups, has shown that a genetic variant in the 5q11 chromosome, which is associated with susceptibility to developing multiple sclerosis, greatly regulates a gene known as ANKRD55.
In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the disease.
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.
Related Multiple Sclerosis Reading:
Multiple Sclerosis For Dummies
by Rosalind Kalb (Author), Barbara Giesser (Author), Kathleen Costello (Author)
Your trusted, compassionate guide to living with MS
Being diagnosed with multiple sclerosis (MS) doesn't mean your life is over. Everyone's MS is different and no one can predict exactly what yours will be like. The fact is, lots of people live their lives with MS without making a full-time job of it.
Multiple Sclerosis For Dummies gives you accessible, easy-to-understand information about what happens with MS—what kinds of symptoms it can cause, how it can affect your life at home and at work, what you can do to feel and function better, and how you can protect... View Details
Overcoming Multiple Sclerosis: The Evidence-Based 7 Step Recovery Program
by George Jelinek MD (Author)
Overcoming Multiple Sclerosis is an established and successful program of treatment. Once a diagnosis of MS meant inevitable decline and disability. Now thousands of people around the world are living healthy, active lives on the Overcoming Multiple Sclerosis recovery program. Overcoming Multiple Sclerosis explains the nature of MS and outlines an evidence-based 7 step program for recovery. Professor George Jelinek devised the program from an exhaustive analysis of medical research when he was first diagnosed with MS in 1999. It has been refined through major ongoing international clinical... View Details
Live Your LIfe, Not Your Diagnosis: How to Manage Stress and Live Well with Multiple Sclerosis
by Andrea Hanson (Author)
Live Your Life, Not Your Diagnosis was previously published as The Inside Guide to MS. The book was updated to include a foreword. “One size fits all” doesn’t exist when you’re living with a diagnosis. You are unique. Your plan to live well with MS must be unique as well. Discussing everything from diet and exercise to stress and emotion management, this book provides you with tools to help you find what works for you. Written by a master certified life coach who was diagnosed with MS in 2000, this book combines stories of bravery (and tantrums), support, and detailed... View Details
Multiple Sclerosis and (lots of) Vitamin D: My Eight-Year Treatment with The Coimbra Protocol for Autoimmune Diseases
by Ana Claudia Domene (Author)
"The Coimbra Protocol relies on doses of vitamin D that range from 40,000 IU to 200,000 IU per day." Mounting scientific evidence clearly shows that vitamin D has a powerful effect on autoimmune diseases, yet most doctors continue to prescribe no more than 1,000 IU or 2,000 IU a day to patients that suffer from such conditions. In this book, Ana Claudia Domene describes her experience with multiple sclerosis and the treatment that has radically eased her symptoms, allowed her to discontinue all conventional medications, and restored her health. Developed by Dr. Cicero Galli Coimbra, a... View Details
Overcoming Multiple Sclerosis Cookbook: Delicious Recipes for Living Well with a Low Saturated Fat Diet
by Ingrid Adelsberger (Editor)
There is no cure for Multiple Sclerosis, but you can make a real difference by changing what you eat. Medical research shows that a diet very low in saturated fat can reduce the disease's progression and even reverse its course in some cases. This cookbook gathers more than 200 favorite recipes from people with MS around the world. They are delicious, wholefood, meat-free, and dairy-free recipes for home cooks. The recipes include quick and easy lunches and dinners, a variety of seafood dishes, luxurious weekend breakfasts, special occasion cakes, and holiday baking. There are vegan and... View Details
Healing Multiple Sclerosis: Diet, Detox & Nutritional Makeover for Total Recovery, New Revised Edition
by Ann Boroch (Author)
This new, expanded edition (revised in 2014) gives a breakthrough treatment protocol that can restore health to those with multiple sclerosis. Even though MS is widely believed to be unbeatable, Ann Boroch, certified nutritional consultant and naturopath, has developed a breakthrough treatment protocol that is having dramatic results.
This landmark work describes how she cured herself of MS using complementary medicine, the real causes of MS, case histories of those who have triumphed over multiple sclerosis, and a comprehensive how-to section that will show you how to develop... View Details
The Wahls Protocol: A Radical New Way to Treat All Chronic Autoimmune Conditions Using Paleo Principles
by Terry Wahls M.D. (Author), Eve Adamson (Author)
An integrative approach to healing chronic autoimmune conditions by a doctor, researcher, and sufferer of progressive multiple sclerosis (MS) whose TEDx talk is already a web sensation
Like many physicians, Dr. Terry Wahls focused on treating her patients’ ailments with drugs or surgical procedures—until she was diagnosed with multiple sclerosis (MS) in 2000. Within three years, her back and stomach muscles had weakened to the point where she needed a tilt-recline wheelchair. Conventional medical treatments were failing her, and she feared that she would be bedridden for... View Details
Multiple Sclerosis, Fifth Edition: A Guide for the Newly Diagnosed
by T.Jock Murray MD (Author)
Now in its fifth edition, Multiple Sclerosis: A Guide for the Newly Diagnosed is the best-selling guide to MS for newly diagnosed patients and their families. Written in plain language by renowned MS expert physician T. Jock Murray, this book guides patients at any stage who want to know more about the disease, its potential impact on their lives, and the medical treatments now available for managing it successfully.
The fifth edition is updated to reflect recent advances in understanding the underlying mechanisms and disease progression, the diagnostic criteria and... View Details
Multiple Sclerosis: A Guide for the Newly Diagnosed: Fourth Edition
by Dr. T. Jock Murray MS (Author), Carol Saunders BA BSN MSCN (Author), Dr. Nancy Holland RN EdD (Author)
"This book has been written for those newly diagnosed with multiple sclerosis. It is a guide to learning about the disease, its potential impact on your life, and the medical treatments now available for managing it successfully. This is a time of great excitement in research and advances in clinical management, such that most people who have multiple sclerosis can lead full and productive lives.
This fourth edition is current and updated throughout, and includes a review of the controversy surrounding CCVSI and multiple sclerosis, discussion of the new pill Gelenya and other drugs in... View Details
Awkward Bitch: My Life with MS
by Marlo Donato Parmelee (Author)
. View Details